Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Recs

0
Player Avatar Fiskhus (71.50) Submitted: 7/26/2013 9:10:52 PM : Outperform Start Price: $2.38 LXRX Score: -31.58

s50>39/s125>65/s250>70/s13>14

Featured Broker Partners


Advertisement